Isn't it strange that we'll spend billions on treating diseases we could simply switch off at the source? We don't question vaccines, which reprogram the immune system. We don't question IVF, which selects embryos. Gene editing to eliminate hereditary diseases is just the next logical step in the same direction—prevention over suffering. I understand the fear of designer babies. That slippery slope argument gets thrown around a lot. But here's the thing: the line isn't that hard to draw. We're talking about eliminating conditions that cause real pain—cystic fibrosis, Huntington's, Tay-Sachs. That's not enhancement; that's healthcare. We already accept that some genetic information is so dangerous we act on it. We abort, we screen, we discard embryos. If we have a tool that's more precise and less destructive, we should use it. The real risk isn't the technology. It's letting perfect become the enemy of merciful.

The strongest argument for gene editing is that we already accept genetic selection when it reduces suffering—we just do it clumsily. We abort fetuses with Tay-Sachs. We discard embryos with cystic fibrosis. That's not "playing God"; that's making a choice about who gets to suffer. Gene editing is the same choice, but more precise and more merciful. Now, I hear the safety concerns, and they're legitimate. CRISPR isn't perfect, off-target mutations happen. But that's an argument for careful clinical trials and regulation, not for banning the technology outright. We don't ban cars because they crash, we improve them. And unlike cars, this technology directly targets agony—Huntington's disease destroys whole families, and we currently have nothing but waiting. The designer baby fear? That's a real conversation, but it's separate. We can draw a bright line between treating disease and enhancing traits. In fact, if we refuse to edit for disease because we're afraid of what someone might do later, we're letting a hypothetical abuse block a concrete act of compassion. That's backwards.

The safety worries are real, but look at how we handle every transformative medical breakthrough. We didn't ban anesthesia because early doses were imprecise. We refined it. The same logic applies to CRISPR. Off-target mutations are a reason for rigorous regulation, not a reason to let children keep inheriting Huntington's. And honestly, the slippery slope argument cuts both ways. We already draw lines every day in medicine—we don't let people amputate healthy limbs, but we amputate gangrenous ones. Disease editing is the gangrene case. The line between healing and enhancement isn't some mystical boundary; it's the difference between restoring health and chasing perfection. We have the moral bandwidth to hold that distinction. What I find strange is that we accept the horrible lottery of birth as natural, but we treat a precise cure as unnatural. The only risk I see worth taking is the risk of doing nothing. And that risk is measured in suffering, not in hypothetical futures.